inmed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. inmed's proprietary platf

InMed Pharmaceuticals Inc. Common Shares

Sold all INM

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Swapnil Patel

New position in INM

Taylor Asplund

Chris arnold

Sold 29% of INM

Sold 36% of INM

Bought 10% more INM

Bought 25% more INM

Bought 33% more INM

Bought 50% more INM

Kevin Lau